| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.25 |
4e-12 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
1e-10 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-09 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-06 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.2 |
1e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |